A randomized study of hyperbaric oxygen as an adjunct to regularly fractionated radiation therapy for clinical treatment of advanced neoplastic disease.
D000328:Adult; D000368:Aged; D001932:Brain Neoplasms / Q000532:radiotherapy / Q000628:therapy; D002294:Carcinoma, Squamous Cell / Q000532:radiotherapy / Q000628:therapy; D003036:Cobalt Isotopes; D004938:Esophageal Neoplasms / Q000532:radiotherapy / Q000628:therapy; D005260:Female; D005909:Glioblastoma / Q000532:radiotherapy / Q000628:therapy; D006258:Head and Neck Neoplasms / Q000532:radiotherapy / Q000628:therapy; D006801:Humans; D006931:Hyperbaric Oxygenation; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000401:mortality / Q000628:therapy*; D011867:Radioisotope Teletherapy; D012004:Rectal Neoplasms / Q000532:radiotherapy / Q000628:therapy; D013679:Technology, Radiologic; D001749:Urinary Bladder Neoplasms / Q000532:radiotherapy / Q000628:therapy; D002583:Uterine Cervical Neoplasms / Q000532:radiotherapy / Q000628:therapy
D003036:Cobalt Isotopes